Physician profile
Munawar Ali
NPI 1508960030
$12,662.37
in general payments reported to CMS, 2019-2025
14 companies · $510 in 2025
The $510 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,514 · 2020: $958 · 2021: $1,916 · 2022: $1,518 · 2023: $1,167 · 2024: $3,078 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,548 · Travel and Lodging: $2,208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,547.60 |
| Travel and Lodging | $2,208.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $4,893.24 | 2021-2024 | Persona, Avenir |
| Stryker Corporation | $1,938.22 | 2019-2025 | Accolade, Mako |
| Pylant Medical | $1,923.02 | 2019-2021 | |
| Arthrex, INC. | $1,649.82 | 2019-2020 | |
| Axogen | $1,093.91 | 2019-2025 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Acumed LLC | $336.65 | 2023-2025 | Acumed, Innate Implant, Acumed |
| Acera Surgical, INC. | $308.49 | 2024 | Restrata Wound Matrix |
| Total Joint Orthopedics, INC. | $180.89 | 2024 | |
| Polynovo North America LLC | $147.13 | 2024 | Novosorb Btm |
| Extremity Medical | $76.62 | 2021 | |
| Skeletal Dynamics INC | $42.65 | 2019 | |
| Ethicon US, LLC | $37.75 | 2025 | Stratafix, Ethicon |
| Depuy Synthes Sales INC. | $18.81 | 2025 | Tfn-Advance |
| Novartis Pharmaceuticals Corporation | $15.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Munawar Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.